Table 2.
Immunohistochemistry findings in small cell carcinoma of the urinary bladder.
| Antibody | No of studies | % of positives staining (mean) |
|---|---|---|
| Neuroendocrine markers | ||
| NSE[2,9,11,23] | 4 | 25-100% (88.5%) |
| Synaptophysin[2,11,9] | 3 | 66.6-76% (72.4%) |
| Serotonin[23] | 1 | 78% |
| Chromogranin[2,9,11,17] | 4 | 22-89% (50%) |
| Epithelial markers | ||
| Cytokeratin[2,23] | 2 | 70-77% (75%) |
| EMA[2] | 1 | 77.7% |
| CK7[24] | 1 | 59% |
| CAM 5.2[2,11,9] | 3 | 47-66.6% (41%) |
| Other markers | ||
| S-100 protein[23] | 1 | 40% |
| TTF1[24,25] | 2 | 39-50% (40%) |
| EGFR[9,26] | 2 | 27-36% (28.6%) |
| C-KIT[9,27] | 2 | 22-27% (27%) |
| CD44v6[11] | 1 | 7% |
| PDGFR[28] | 1 case report | + |
Abbreviations. NSE = neuron specific enolase; EMA = epithelial membrane antigen; CK7 = cytokeratine 7; EGFR = epidermal growth factor receptor; PDGFR = platelet derived growth factor